The medical device market is expected to grow to almost $800 billion by 2030. Here's a list of the year's best opportunities. The United States has a $115.5 billion trade deficit in pharmaceutical ...

Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their businesses. About one in every eight U.S. adults is currently taking a ...

The GLP-1 market remains one of the great unknowns in food and beverage. That’s mostly because it really only entered the mainstream in the past five years. But, while it might be new to many, it’s ...